Nasdaq - Delayed Quote USD

T. Rowe Price Health Sciences I (THISX)

97.11 -0.12 (-0.12%)
As of 8:06 AM EST. Market Open.
Loading Chart for THISX
DELL
  • Previous Close 97.23
  • YTD Return 8.70%
  • Expense Ratio 0.67%
  • Category Health
  • Last Cap Gain 49.00
  • Morningstar Rating
  • Morningstar Risk Rating Above Average
  • Sustainability Rating
  • Net Assets 14.59B
  • Beta (5Y Monthly) 0.75
  • Yield 0.00%
  • 5y Average Return --
  • Holdings Turnover 48.40%
  • Last Dividend 0.14
  • Inception Date Dec 29, 1995

The fund normally invests at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies.

T. Rowe Price

Fund Family

Health

Fund Category

14.59B

Net Assets

1995-12-29

Inception Date

Performance Overview: THISX

View More

Trailing returns as of 12/2/2024. Category is Health.

YTD Return

THISX
8.70%
Category
7.95%
 

1-Year Return

THISX
22.03%
Category
30.16%
 

3-Year Return

THISX
1.12%
Category
16.10%
 

5-Year Return

THISX
10.23%
Category
15.71%
 

People Also Watch

Holdings: THISX

View More

Top 9 Holdings (43.72% of Total Assets)

SymbolCompany% Assets
LLY
Eli Lilly and Company 10.50%
UNH
UnitedHealth Group Incorporated 7.20%
TMO
Thermo Fisher Scientific Inc. 4.97%
ISRG
Intuitive Surgical, Inc. 4.72%
DHR
Danaher Corporation 4.00%
SYK
Stryker Corporation 3.55%
MRK
Merck & Co., Inc. 3.04%
REGN
Regeneron Pharmaceuticals, Inc. 2.89%
ELV
Elevance Health, Inc. 2.86%

Sector Weightings

SectorTHISX
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Recent News: THISX

View More

Research Reports: THISX

View More

Top Mutual Funds